Literature DB >> 12204774

Anticancer activity of Hemsleya amabilis extract.

Jin Wu1, Yaojiong Wu, Burton B Yang.   

Abstract

Hemsleya amabilis extract is derived from the medicinal herb Hemsleya amabilis, which has long been used to treat cancer and many other conditions. The underlying mechanism is not clear. To investigate Hemsleya amabili's anticancer activity, we have treated different types of cancer cells including human astrocytoma U87 cells, breast cancer cells MDA-MB-231and Jurkat cells with Hemsleya amabilis extract. This agent significantly inhibited tumor cell growth and colony formation at various concentrations. When astrocytoma cells were seeded in the presence of Hemsleya amabilis extract at very low concentrations, cell spreading was greatly inhibited. Hemsleya amabilis extract also promoted tumor cell death in all the tested cell lines, but with varied sensitivities. Apoptotic assays with Annexin V staining demonstrated that Hemsleya amabilis extract induced astrocytoma cell apoptosis at different concentrations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204774     DOI: 10.1016/s0024-3205(02)02013-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

Review 1.  Natural products and their role in cancer therapy.

Authors:  David Siu
Journal:  Med Oncol       Date:  2010-04-23       Impact factor: 3.064

2.  Antiproliferation and apoptosis on RKO colon cancer by Millingtonia hortensis.

Authors:  Siwapong Tansuwanwong; Hiroyuki Yamamoto; Kohzoh Imai; Usanee Vinitketkumnuen
Journal:  Plant Foods Hum Nutr       Date:  2009-03       Impact factor: 3.921

Review 3.  Use of cucurbitacins for lung cancer research and therapy.

Authors:  Min Liu; Qijia Yan; Bi Peng; Yuan Cai; Shuangshuang Zeng; Zhijie Xu; Yuanliang Yan; Zhicheng Gong
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-06       Impact factor: 3.333

4.  Antiproliferative Properties of Clausine-B against Cancer Cell Lines.

Authors:  Wan Nor I'zzah Wan Mohd Zain; Asmah Rahmat; Fauziah Othman; Taufiq Yun Hin Yap
Journal:  Malays J Med Sci       Date:  2009-07

5.  Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation.

Authors:  C Boykin; G Zhang; Y-H Chen; R-W Zhang; X-E Fan; W-M Yang; Q Lu
Journal:  Br J Cancer       Date:  2011-02-08       Impact factor: 7.640

6.  Ergosterol purified from medicinal mushroom Amauroderma rude inhibits cancer growth in vitro and in vivo by up-regulating multiple tumor suppressors.

Authors:  Xiangmin Li; Qingping Wu; Yizhen Xie; Yinrun Ding; William W Du; Mouna Sdiri; Burton B Yang
Journal:  Oncotarget       Date:  2015-07-10

7.  Ergosterol peroxide activates Foxo3-mediated cell death signaling by inhibiting AKT and c-Myc in human hepatocellular carcinoma cells.

Authors:  Xiangmin Li; Qingping Wu; Ming Bu; Liming Hu; William W Du; Chunwei Jiao; Honghui Pan; Mouna Sdiri; Nan Wu; Yizhen Xie; Burton B Yang
Journal:  Oncotarget       Date:  2016-06-07

8.  Inhibition of Cell Growth and Cellular Protein, DNA and RNA Synthesis in Human Hepatoma (HepG2) Cells by Ethanol Extract of Abnormal Savda Munziq of Traditional Uighur Medicine.

Authors:  Halmurat Upur; Abdiryim Yusup; Isabelle Baudrimont; Anwar Umar; Benedicte Berke; Dilxat Yimit; Jaya Conser Lapham; Edmon E Creppy; Nicholas Moore
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-18       Impact factor: 2.629

9.  Intrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell line.

Authors:  Shahrul Hisham Zainal Ariffin; Wan Haifa Haryani Wan Omar; Zaidah Zainal Ariffin; Muhd Fauzi Safian; Sahidan Senafi; Rohaya Megat Abdul Wahab
Journal:  Cancer Cell Int       Date:  2009-03-03       Impact factor: 5.722

10.  In-vitro Assessment of the Antiproliferative and Apoptotic Potential of the Ethyl acetate Extract of Peltophorumafricanum on Different Cancer Cell Lines.

Authors:  Benjamin Ifeoluwa Okeleye; Noxolo Thabiso Mkwetshana; Roland Ndip Ndip
Journal:  Iran J Pharm Res       Date:  2017       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.